Patrik Brundin (Former)
131 – 140 of 248
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Stem cell-based therapy for Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
-
Mark
Stem cell therapy for Parkinson's disease: where do we stand?
(
- Contribution to journal › Scientific review
-
Mark
Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra.
(
- Contribution to journal › Article
- 2003
-
Mark
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg
(
- Contribution to journal › Scientific review